Comment on: ‘One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration’
Saved in:
Published in | Eye (London) Vol. 32; no. 2; pp. 477 - 479 |
---|---|
Main Author | |
Format | Journal Article |
Language | English |
Published |
London
Nature Publishing Group UK
01.02.2018
Nature Publishing Group |
Subjects | |
Online Access | Get full text |
Cover
Loading…
Author | Nestel, A R |
---|---|
Author_xml | – sequence: 1 givenname: A R surname: Nestel fullname: Nestel, A R email: achimnestel@nhs.net organization: Department of Ophthalmology, North Devon District Hospital |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29026187$$D View this record in MEDLINE/PubMed |
BookMark | eNptkc1u1DAUhS1URKeFHWsUiQ0LPPg6djxhgYRG5Ueq1E0X7CzHuQmuEnuwk4HZ9QlYl9frk-DRlKogVpFzPn320TkhRz54JOQ5sCWwcvUGd7jkDNSSAzwiCxCqolJIcUQWrJaMcs6_HJOTlK4Yy6FiT8gxrxmvYKUW5Oc6jCP6qQj-bXF7fXPhke7QxCKiGej3EIe2CPNkw4ipcL7YmMllPOXcots63xed-4EtbUPaH0w3uAajxc1UdCEWHsPWJDsPWWl6pBEHM2FbjObwr8UePcZsDf72-tdT8rgzQ8Jnd99Tcvnh7HL9iZ5ffPy8fn9OrWBqokJwDqJWprEl1tg00NSKlR0Yibm6KSuUK6kUtlIhWNnUXFgjwNrSAprylLw7aDdzM2Jrc6NoBr2JbjRxp4Nx-u_Eu6-6D1stVwCKyyx4dSeI4duMadKjSxaHweTCc9JQS5AVr8oqoy__Qa_CHH1ul6m6BgVc7KnXB8rGkFLE7v4xwPR-Z5131vuddd454y8eFriH_wybAXoAUo58j_HBrf8T_ga-5LoK |
Cites_doi | 10.1016/j.ophtha.2012.04.015 10.1038/eye.2017.6 |
ContentType | Journal Article |
Copyright | Macmillan Publishers Limited, part of Springer Nature. 2018 Copyright Nature Publishing Group Feb 2018 Copyright © 2018 Macmillan Publishers Limited, part of Springer Nature. 2018 Macmillan Publishers Limited, part of Springer Nature. |
Copyright_xml | – notice: Macmillan Publishers Limited, part of Springer Nature. 2018 – notice: Copyright Nature Publishing Group Feb 2018 – notice: Copyright © 2018 Macmillan Publishers Limited, part of Springer Nature. 2018 Macmillan Publishers Limited, part of Springer Nature. |
DBID | CGR CUY CVF ECM EIF NPM AAYXX CITATION 3V. 7TK 7X7 7XB 88E 8AO 8FE 8FH 8FI 8FJ 8FK ABUWG AFKRA AZQEC BBNVY BENPR BHPHI CCPQU DWQXO FYUFA GHDGH GNUQQ HCIFZ K9. LK8 M0S M1P M7P PQEST PQQKQ PQUKI PRINS 7X8 5PM |
DOI | 10.1038/eye.2017.211 |
DatabaseName | Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed CrossRef ProQuest Central (Corporate) Neurosciences Abstracts Health Medical collection ProQuest Central (purchase pre-March 2016) Medical Database (Alumni Edition) ProQuest Pharma Collection ProQuest SciTech Collection ProQuest Natural Science Collection Hospital Premium Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Central (Alumni) ProQuest Central ProQuest Central Essentials Biological Science Collection AUTh Library subscriptions: ProQuest Central ProQuest Natural Science Collection ProQuest One Community College ProQuest Central Korea Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student SciTech Premium Collection (Proquest) (PQ_SDU_P3) ProQuest Health & Medical Complete (Alumni) Biological Sciences Health & Medical Collection (Alumni Edition) Medical Database Biological Science Database ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China MEDLINE - Academic PubMed Central (Full Participant titles) |
DatabaseTitle | MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) CrossRef ProQuest Central Student ProQuest Central Essentials ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) SciTech Premium Collection ProQuest One Community College ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Central China ProQuest Central Health Research Premium Collection Health and Medicine Complete (Alumni Edition) Natural Science Collection ProQuest Central Korea Biological Science Collection ProQuest Medical Library (Alumni) ProQuest Biological Science Collection ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest SciTech Collection Neurosciences Abstracts ProQuest Hospital Collection (Alumni) ProQuest Health & Medical Complete ProQuest Medical Library ProQuest One Academic UKI Edition ProQuest One Academic ProQuest Central (Alumni) MEDLINE - Academic |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine |
DocumentTitleAlternate | Correspondence |
EISSN | 1476-5454 |
EndPage | 479 |
ExternalDocumentID | 10_1038_eye_2017_211 29026187 |
Genre | Letter Comment Commentary Correspondence |
GroupedDBID | --- -Q- .GJ 0R~ 29G 2WC 36B 39C 3O- 3V. 4.4 406 53G 5RE 6PF 70F 7X7 88E 8AO 8FI 8FJ 8R4 8R5 AACDK AANZL AASML AATNV AAWBL AAWTL AAZLF ABAKF ABAWZ ABCQX ABDBF ABJNI ABLJU ABUWG ABZZP ACAOD ACGFS ACKTT ACPRK ACRQY ACZOJ ADBBV ADHDB AEFQL AEJRE AEMSY AENEX AEVLU AEXYK AFBBN AFFNX AFKRA AFSHS AGAYW AGEZK AGHAI AGQEE AHMBA AHSBF AIGIU AILAN AJRNO ALFFA ALIPV ALMA_UNASSIGNED_HOLDINGS AMYLF AOIJS AXYYD B0M BAWUL BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DIK DNIVK DPUIP E3Z EAD EAP EBC EBD EBLON EBS EBX EE. EIOEI EJD EMB EMK EMOBN EPL ESX F5P FDQFY FERAY FIGPU FIZPM FSGXE FYUFA GX1 HCIFZ HMCUK HYE HZ~ IWAJR JSO JZLTJ KQ8 L7B M1P M7P NAO NQJWS O9- OK1 P2P PQQKQ PROAC PSQYO Q2X RNS RNT RNTTT RPM SNX SNYQT SOHCF SRMVM SV3 SWTZT TAOOD TBHMF TDRGL TR2 TUS UKHRP W2D ZGI ZXP ~8M AAYZH CGR CUY CVF ECM EIF NPM AAYXX CITATION 7TK 7XB 8FE 8FH 8FK AZQEC DWQXO GNUQQ K9. LK8 PQEST PQUKI PRINS 7X8 5PM |
ID | FETCH-LOGICAL-c407t-44221497abc3e9ebb1b9703f1a5e454a36e58577ed57e1c5b924ca41cc3c1ea3 |
IEDL.DBID | RPM |
ISSN | 0950-222X |
IngestDate | Tue Sep 17 21:20:14 EDT 2024 Fri Aug 16 21:19:48 EDT 2024 Thu Oct 10 20:40:18 EDT 2024 Thu Sep 26 19:50:24 EDT 2024 Wed Oct 16 00:51:53 EDT 2024 Fri Oct 11 20:50:15 EDT 2024 |
IsDoiOpenAccess | false |
IsOpenAccess | true |
IsPeerReviewed | true |
IsScholarly | true |
Issue | 2 |
Language | English |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c407t-44221497abc3e9ebb1b9703f1a5e454a36e58577ed57e1c5b924ca41cc3c1ea3 |
Notes | SourceType-Other Sources-1 content type line 63 ObjectType-Correspondence-1 ObjectType-Commentary-2 |
OpenAccessLink | https://www.nature.com/articles/eye2017211.pdf |
PMID | 29026187 |
PQID | 1999171246 |
PQPubID | 33647 |
PageCount | 3 |
ParticipantIDs | pubmedcentral_primary_oai_pubmedcentral_nih_gov_5811725 proquest_miscellaneous_1951562636 proquest_journals_1999171246 crossref_primary_10_1038_eye_2017_211 pubmed_primary_29026187 springer_journals_10_1038_eye_2017_211 |
PublicationCentury | 2000 |
PublicationDate | 2018-02-01 |
PublicationDateYYYYMMDD | 2018-02-01 |
PublicationDate_xml | – month: 02 year: 2018 text: 2018-02-01 day: 01 |
PublicationDecade | 2010 |
PublicationPlace | London |
PublicationPlace_xml | – name: London – name: England |
PublicationSubtitle | The Scientific Journal of The Royal College of Ophthalmologists |
PublicationTitle | Eye (London) |
PublicationTitleAbbrev | Eye |
PublicationTitleAlternate | Eye (Lond) |
PublicationYear | 2018 |
Publisher | Nature Publishing Group UK Nature Publishing Group |
Publisher_xml | – name: Nature Publishing Group UK – name: Nature Publishing Group |
References | Almuhtaseb, Kanavati, Rufai, Lotery (CR1) 2017; 31 Chakravarthy, Harding, Rogers, Downes, Lotery, Wordsworth (CR2) 2012; 119 28186507 - Eye (Lond). 2017 Jun;31(6):878-883 29052610 - Eye (Lond). 2018 Feb;32(2):479-481 U Chakravarthy (BFeye2017211_CR2) 2012; 119 H Almuhtaseb (BFeye2017211_CR1) 2017; 31 |
References_xml | – volume: 119 start-page: 1399 issue: 7 year: 2012 end-page: 1411 ident: CR2 article-title: Ranibizumab versus bevacizumab to treat neovascular age-related macular degeneration: one-year findings from the IVAN randomized trial publication-title: Ophthalmology doi: 10.1016/j.ophtha.2012.04.015 contributor: fullname: Wordsworth – volume: 31 start-page: 878 issue: 6 year: 2017 end-page: 883 ident: CR1 article-title: One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration publication-title: Eye doi: 10.1038/eye.2017.6 contributor: fullname: Lotery – volume: 31 start-page: 878 issue: 6 year: 2017 ident: BFeye2017211_CR1 publication-title: Eye doi: 10.1038/eye.2017.6 contributor: fullname: H Almuhtaseb – volume: 119 start-page: 1399 issue: 7 year: 2012 ident: BFeye2017211_CR2 publication-title: Ophthalmology doi: 10.1016/j.ophtha.2012.04.015 contributor: fullname: U Chakravarthy |
SSID | ssj0014770 |
Score | 2.2317803 |
SourceID | pubmedcentral proquest crossref pubmed springer |
SourceType | Open Access Repository Aggregation Database Index Database Publisher |
StartPage | 477 |
SubjectTerms | 692/699/3161/1626 692/700/3934 Age Angiogenesis Inhibitors Correspondence Humans Intravitreal Injections Laboratory Medicine Macular Degeneration Medicine Medicine & Public Health Ophthalmology Pharmaceutical Sciences/Technology Ranibizumab Receptors, Vascular Endothelial Growth Factor Recombinant Fusion Proteins Surgery Surgical Oncology Treatment Outcome Wet Macular Degeneration |
SummonAdditionalLinks | – databaseName: AUTh Library subscriptions: ProQuest Central dbid: BENPR link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9QwDLfGJiFeEIyPFQbKJGBPYUuTNi0vaJs2TUgbCA3p3qo09cFJox3cncT-hf3Vs9Nc4di018ZK0zj1R2z_DPAmtY0y1pUSHWpJ-rqQdVE4mWOukCxYg8iFwien-fE382mUjeKF2zSmVS5kYhDUTef5jnyHy-WVJW2Uf7z4JblrFEdXYwuNe7CWKsNh2rX9w9MvX4c4grGhXRzZEbuSNOEopr7v6mIHLxklU9n3qVLLSumGpXkzYfK_qGlQRkeP4GG0IsVez_bHsILtOtw_iXHyJ3DFdR80i-jaD2L7c4vykk60IAPxXAaMVNHNZ_TdOBWTVkRs1SmNe5zwDYMYT_5gI5uObxKEG4ckFE6AEWTjihaHBFZB4kiGehhsxE_XP2vwewCzZp5vP4Wzo8Ozg2MZuy5IT87dTBqT0l6W1tVeY4l1reqSxMJYuQxNZpzOkVwMa7HJLCqf1eTBeWeU99ordPoZrLZdixsguIWZpklc7sfGG1trmyF5bAxAk5Nfk8Dbxa5XFz22RhVi4rqoiDsVc6ci7iSwuWBJFf-wafX3PCSwNQzTv8EBD0cbMWcastYYbodonvccHF6Ulux9FjYBu8TbgYBxt5dH2smPgL-dcXFumiXwbnEK_lnWLet_cff6X8IDoiz6VPBNWJ39nuMrsnRm9et4nK8BIgMASw priority: 102 providerName: ProQuest |
Title | Comment on: ‘One-year real-world outcomes in patients receiving fixed-dosing aflibercept for neovascular age-related macular degeneration’ |
URI | https://link.springer.com/article/10.1038/eye.2017.211 https://www.ncbi.nlm.nih.gov/pubmed/29026187 https://www.proquest.com/docview/1999171246 https://search.proquest.com/docview/1951562636 https://pubmed.ncbi.nlm.nih.gov/PMC5811725 |
Volume | 32 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1NT9wwEB0Blapeqn43QFeu1PbmXRw7cba3FoFQpaWootLeIseZpZHYLOruSnDjF3Auf49fwoyTrKD01GtsOZZnHL_JvHkG-BDbUhnrhhIdaknndSaLLHMyxVQhIViDyIXCo8P04Kf5Nk7Ga5B0tTCBtO-Lql-fTvt19StwK8-mftDxxAZHo92EqyPjZLAO61brLkRvUwfGhhviCDrsSDr8xi3bfUdnA7xgYUxl-xT1sArwkAMQJtPdPZIe4MyHdMm_cqbhKNp_Bk9bDCm-NHN9DmtYv4DHozZL_hKuuOqDRhGz-rO4ufzzvUZ5QR4tCCCeyqCRKmbLBfkazkVVi1ZbdU7tHiv-wyAm1TmWspzxnwThJoGEwgQYQRhX1LgisAr6HMlQD4OlmLrmWYknQcyabX5zef0Kjvf3jncPZHvvgvQU3i2kMXFMgZN1hdc4xKJQxZA-DBPlEjSJcTpFCjKsxTKxqHxSUAznnVHea6_Q6dewUc9qfAuCLzHTNIhL_cR4YwttE6Q1ZwkaWvk4go_dyudnjbpGHrLiOsvJWDkbKydjRbDdmSVv99g8ZwEFZQmfpBG8XzXT7uCUh6OlWHIfwmssuEN93jRWXL2oM38E9p59Vx1Yeft-CzlkUOBuHTCCT50n3JnWP-a_-d-v2IInNEjW8MS3YWPxe4nvCAYtih45_9j24NHXvcOjH72wCW4Bp_cN-w |
link.rule.ids | 230,315,733,786,790,891,12083,21416,27955,27956,31752,31753,33777,33778,43343,43838,53825,53827,74100,74657 |
linkProvider | National Library of Medicine |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV1fb9QwDLfGkIAXNP6NwoAgAXvKtjRp0-MFIbTp2Hbj5ZDurUpT3zgJ2sHdSewr8Klnp7nCMcRrk6Zp7MR2bP8M8Cq1tTLWDSQ61JLkdSGronAyx1whabAGkROFR2f58LM5nmSTeOE2j2GVqzMxHNR16_mOfJ_T5ZUlaZS_u_guuWoUe1djCY0bcNNobZjP7aQ3uGgSoVgcaREHkuTgJAa-H-hiHy8ZI1PZvVSpdZF0Tc-8Hi75l880iKKjLbgbdUjxviP6PdjA5j7cGkUv-QP4xVkfNIpom7di91OD8pL4WZB6-FUGhFTRLhf01zgXs0ZEZNU5tXuc8f2CmM5-Yi3rlu8RhJuGEBQOfxGk4YoG-_BVQYeRDNkwWItvrntW43mAsmaK7z6E8dHh-MNQxpoL0pNpt5DGpCkZTdZVXuMAq0pVAzoUpsplaDLjdI5kYFiLdWZR-awi-807o7zXXqHTj2CzaRt8DIILmGkaxOV-aryxlbYZkr3G8DM5WTUJvF6tennRIWuUwSOui5KoUzJ1SqJOAjsrkpRxf83L39yQwMu-mXYGuzscLcSS-5CuxmA71Ge7o2D_oXTAtmdhE7BrtO07MOr2eksz-xLQtzNOzU2zBN6suOCPaf1j_k_-P_8XcHs4Hp2Wpx_PTp7CHXqr6ILCd2Bz8WOJz0jnWVTPA2NfAf6iAdI |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwfV3db9MwED_BkCZeJr4JDDASsCfTOnbidC8IAdX42OBhSH2LHOfCKkEyaCuxf4G_eneOGyhDvNZOavkuvjvf734H8CS1tTLWTSQ61JLsdSGronAyx1whebAGkQuFD4_yg8_m3SybRfzTIsIq12diOKjrzvMd-YjL5ZUla5SPmgiL-PR6-uL0u-QOUpxpje00LsMVspJjbuNgZ0PwRQsKjePIoxhLsomzCIIf62KEZ8yXqezzVKlN83TB57wInfwrfxrM0vQa7ER_UrzsFeA6XML2Bmwfxoz5TfjFFSD0FtG1-2LvY4vyjHRbkKv4VQa2VNGtlrQDuBDzVkSW1QWNe5zzXYNo5j-xlnXHdwrCNQGOwlAYQd6uaHGAsgo6mGSojMFafHP9bzV-CbTWLP29W3A8fXP86kDG_gvSU5i3lMakKQVQ1lVe4wSrSlUTOiAa5TI0mXE6Rwo2rMU6s6h8VlEs551R3muv0OnbsNV2Ld4Fwc3MNL3E5b4x3thK2wwpdmMqmpwinASerne9PO1ZNsqQHddFSdIpWTolSSeB3bVIyvitLcrfmpHA42GYvhJOfTjaiBXPIb-NiXdozp1egsMfpROOQwubgN2Q7TCBGbg3R9r5SWDizrhMN80SeLbWgj-W9Y_13_v_-h_BNul0-eHt0fv7cJUeKnp8-C5sLX-s8AG5P8vqYdDrc9rPBf4 |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Comment+on%3A+%E2%80%98One-year+real-world+outcomes+in+patients+receiving+fixed-dosing+aflibercept+for+neovascular+age-related+macular+degeneration%E2%80%99&rft.jtitle=Eye+%28London%29&rft.au=Nestel%2C+A+R&rft.date=2018-02-01&rft.pub=Nature+Publishing+Group+UK&rft.issn=0950-222X&rft.eissn=1476-5454&rft.volume=32&rft.issue=2&rft.spage=477&rft.epage=479&rft_id=info:doi/10.1038%2Feye.2017.211&rft.externalDocID=10_1038_eye_2017_211 |
thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0950-222X&client=summon |
thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0950-222X&client=summon |
thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0950-222X&client=summon |